PMID: 7526841Oct 15, 1994Paper

Thrombin-receptor agonist peptides, in contrast to thrombin itself, are not full agonists for activation and signal transduction in human platelets in the absence of platelet-derived secondary mediators

The Biochemical Journal
L F LauM B Feinstein

Abstract

Synthetic thrombin receptor peptides (TRPs), comprising the first 6-14 amino acids of the new N-terminus tethered ligand of the thrombin receptor that is generated by thrombin's proteolytic activity, were reported to activate platelets equally with thrombin itself and are considered to be full agonists [Vu et al. (1991) Cell 64, 1057-1068]. Using aspirin plus ADP-scavengers or the ADP-receptor antagonist adenosine 5'-[alpha-thio]triphosphate to prevent the secondary effects of the potent agonists that are normally released from stimulated platelets (i.e. ADP and thromboxane A2), we assessed the direct actions of thrombin and TRPs (i.e. TRP42-47 and TRP42-55). Compared with thrombin, under these conditions, TRPs: (1) failed to aggregate platelets completely; (2) produced less activation of glycoprotein (GP)IIb-IIIa; (3) did not cause association of GPIIb and pp60c-src with the cytoskeleton; and (4) caused less alpha-granule secretion, phosphorylation of cytoplasmic phospholipase A2, arachidonic acid release and phosphatidyl inositol (PtdOH) production. Furthermore, TRPs induced transient increases in protein phosphorylation mediated by protein kinase C and protein tyrosine phosphorylation, whereas these same responses to thrombi...Continue Reading

Citations

Dec 31, 1997·Leukemia & Lymphoma·W F Bahou, D J Demetrick
Jul 25, 2000·British Journal of Pharmacology·C C WuC M Teng
Oct 1, 2005·Journal of Thrombosis and Haemostasis : JTH·C SouletB Payrastre
Nov 10, 2004·British Journal of Pharmacology·Ada W Y ChungMarek W Radomski
Jun 12, 2002·The American Journal of Pathology·Berta FustéJames G White
Feb 5, 2016·British Journal of Pharmacology·Shauna L French, Justin R Hamilton
Nov 10, 2016·PloS One·Nicole R HenschFadi T Khasawneh
Jan 23, 1998·Arteriosclerosis, Thrombosis, and Vascular Biology·R A HenriksenP B Tracy
Dec 6, 2003·Arteriosclerosis, Thrombosis, and Vascular Biology·Xing-Hong LengPaul F Bray
May 15, 2002·Arteriosclerosis, Thrombosis, and Vascular Biology·Ruth Ann Henriksen, Vallere K Hanks
Mar 10, 2010·Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology·D EwenJ K Shute
Jun 21, 2012·Journal of Thrombosis and Haemostasis : JTH·R A SchuepbachM Riewald
Sep 2, 1998·Proceedings of the National Academy of Sciences of the United States of America·Y DjellasG C Le Breton
Apr 18, 1998·Proceedings of the National Academy of Sciences of the United States of America·M I FurmanA D Michelson
Jan 1, 1996·Platelets·M R MirlashariM H Fukami
Jul 5, 2001·The Journal of Peptide Research : Official Journal of the American Peptide Society·J T ElliottG D Prestwich
Jun 5, 1998·The American Journal of Physiology·O DéryN W Bunnett
Dec 13, 2018·Journal of Veterinary Science·Preeti K Chaudhary, Soochong Kim
Feb 1, 1997·Baillière's Clinical Haematology·M P SmithG F Savidge

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.